When the mass incineration of British cattle When the mass incineration of British cattle was a recent memory 5 years ago, cases of was a recent memory 5 years ago, cases of variant Creutzfeldt-Jakob disease (vCJD) variant Creutzfeldt-Jakob disease (vCJD) were increasing each year and educating were increasing each year and educating doctors about the disease was a priority. I doctors about the disease was a priority. I co-reviewed the psychiatric management co-reviewed the psychiatric management of CJD for of CJD for Advances in Psychiatric TreatAdvances in Psychiatric Treatment ment (Butler & Fleminger, 2001 ). There (Butler & Fleminger, 2001 ). There were dire predictions about the impact of were dire predictions about the impact of prion diseases on human health, but what prion diseases on human health, but what has happened since? What is the latest rehas happened since? What is the latest research? And what is the relevance of prion search? And what is the relevance of prion diseases for psychiatrists in the coming diseases for psychiatrists in the coming years? years?
THE THREATENED EPIDEMIC THE THREATENED EPIDEMIC
From the first death in 1995 until the end of From the first death in 1995 until the end of 2005, 153 people died from vCJD in the 2005, 153 people died from vCJD in the UK (http://www.cjd.ed.ac.uk). There have UK (http://www.cjd.ed.ac.uk). There have been about 18 cases of vCJD in France been about 18 cases of vCJD in France and 12 in the rest of the world. The families and 12 in the rest of the world. The families and loved ones of those who died have had and loved ones of those who died have had to contend not only with the disease itself to contend not only with the disease itself but with healthcare systems that were unbut with healthcare systems that were unprepared, often ignorant and unable to proprepared, often ignorant and unable to provide a coordinated response. Some of the vide a coordinated response. Some of the families formed themselves into support families formed themselves into support groups such as the CJD Support Network groups such as the CJD Support Network and the Human BSE Foundation. They have and the Human BSE Foundation. They have lobbied for better services, greater awareness lobbied for better services, greater awareness from health professionals and easier access from health professionals and easier access to potential treatments. A trust has been to potential treatments. A trust has been established to pay compensation to the established to pay compensation to the victims of vCJD and their families (http:// victims of vCJD and their families (http:// www.cjdtrust.co.uk). www.cjdtrust.co.uk).
The number of deaths from vCJD in the The number of deaths from vCJD in the UK appeared to peak in 2000 when 28 peo-UK appeared to peak in 2000 when 28 people died. Last year 5 people died. These ple died. Last year 5 people died. These numbers are surprisingly low in view of numbers are surprisingly low in view of the millions of people who were exposed the millions of people who were exposed to infected beef products in the late to infected beef products in the late 1980s. The transmission barrier may have 1980s. The transmission barrier may have been sufficient to prevent the feared epibeen sufficient to prevent the feared epidemic. Deaths from sporadic CJD continue demic. Deaths from sporadic CJD continue worldwide at about one per million people worldwide at about one per million people per year. per year.
There have been some worrying develThere have been some worrying developments. Cases have been identified in a opments. Cases have been identified in a number of countries around the world, number of countries around the world, and it is likely that people in more countries and it is likely that people in more countries will be affected. Many were resident in the will be affected. Many were resident in the UK at some period, but others were prob-UK at some period, but others were probably exposed in their own country to ably exposed in their own country to indigenous bovine spongiform encephalitis indigenous bovine spongiform encephalitis (BSE) or imports from the UK. (BSE) or imports from the UK.
There has been human to human transThere has been human to human transmission of vCJD via blood products. This mission of vCJD via blood products. This comes with many ethical considerations, comes with many ethical considerations, such as how to deal with those who were such as how to deal with those who were exposed to these blood products (Bird, exposed to these blood products (Bird, 2004) . There remains the risk of trans-2004) . There remains the risk of transmission by dura mater grafts, human pituimission by dura mater grafts, human pituitary hormones or surgical instruments tary hormones or surgical instruments because traditional sterilisation does not because traditional sterilisation does not neutralise prions. Prion diseases are wideneutralise prions. Prion diseases are widespread in animals around the world, includspread in animals around the world, including scrapie in sheep, and are under-tested in ing scrapie in sheep, and are under-tested in some countries. Despite this, BSE has been some countries. Despite this, BSE has been detected in most European countries, detected in most European countries, USA, Canada and Japan. USA, Canada and Japan.
SPOR ADIC, INHERITED SPOR ADIC, INHERITED OR TR ANSMIT TED OR TR ANSMIT TED
Prion diseases are associated with an abnorPrion diseases are associated with an abnormal, protease-resistant form of prion promal, protease-resistant form of prion protein known as scrapie prion protein tein known as scrapie prion protein (Prusiner & Hsiao, 1994) . The function of (Prusiner & Hsiao, 1994) . The function of prion protein is poorly understood. Some prion protein is poorly understood. Some animals genetically engineered to lack the animals genetically engineered to lack the protein appear normal. Attempts to breed protein appear normal. Attempts to breed a prion protein-free cow are proving time a prion protein-free cow are proving time consuming and costly. consuming and costly.
The change in prion protein may occur The change in prion protein may occur in three different ways (Cohen in three different ways (Cohen et al et al, 1994) . , 1994). In sporadic prion disease, prion protein In sporadic prion disease, prion protein changes to the insoluble form spontachanges to the insoluble form spontaneously. Sporadic CJD accounts for most neously. Sporadic CJD accounts for most cases of CJD. In familial vCJD, an abnormcases of CJD. In familial vCJD, an abnormality in the gene coding for prion protein ality in the gene coding for prion protein produces a protein that is unstable and produces a protein that is unstable and changes into the abnormal protein. 
CLINICAL FEATURES CLINICAL FEATURES AND INVESTIGATIONS AND INVESTIGATIONS
Sporadic CJD peaks in incidence at beSporadic CJD peaks in incidence at between 50 and 70 years of age. It is a rapidly tween 50 and 70 years of age. It is a rapidly progressive dementia, often with severe cerprogressive dementia, often with severe cerebellar and extrapyramidal signs and myoebellar and extrapyramidal signs and myoclonus, causing death usually within a few clonus, causing death usually within a few months (Will & Matthews, 1984) . Psychimonths (Will & Matthews, 1984) . Psychiatric symptoms occur early in the disease atric symptoms occur early in the disease in about a third of cases. in about a third of cases.
Variant CJD differs from sporadic CJD Variant CJD differs from sporadic CJD in a number of ways (Will in a number of ways (Will et al et al, 1996) ; the , 1996); the National CJD Surveillance Unit published National CJD Surveillance Unit published the clinical features of the first 100 cases the clinical features of the first 100 cases of vCJD (Spencer of vCJD (Spencer et al et al, 2002) . Onset is , 2002). Onset is usually at a young age, mean 26 years, usually at a young age, mean 26 years, range 12 to 74 years. Patients tend to prerange 12 to 74 years. Patients tend to present to psychiatrists as first-line specialists, sent to psychiatrists as first-line specialists, with early symptoms of dysphoria, withwith early symptoms of dysphoria, withdrawal, anxiety, irritability, insomnia or drawal, anxiety, irritability, insomnia or loss of interest. Neurological symptoms loss of interest. Neurological symptoms occur on average 2 months later. These occur on average 2 months later. These include pain, headaches, dropping things, include pain, headaches, dropping things, sweatiness and loss of consciousness. The sweatiness and loss of consciousness. The combination of a psychiatric disorder with combination of a psychiatric disorder with affective or psychotic features, and persisaffective or psychotic features, and persistent pain, dysarthria, gait ataxia, or sensory tent pain, dysarthria, gait ataxia, or sensory symptoms, should raise the suspicion of symptoms, should raise the suspicion of vCJD, particularly if there is a suggestion vCJD, particularly if there is a suggestion of cognitive impairment. Mean survival is of cognitive impairment. Mean survival is a little over 1 year. a little over 1 year. ( 2 0 0 6 ) , 1 8 9, 2 9 5^2 9 6 . d o i : 1 0 .11 9 2 / b j p . b p .1 0 6 . 0 21 8 3 2 ( 2 0 0 6 ) , 1 8 9, 2 9 5^2 9 6 . d o i : 1 0 .11 9 2 / b j p . b p .1 0 6 . 0 21 8 3 2 
B R I T I S H J O UR N A L O F P SYC HI AT RY B R I T I S H J O UR N A L O F P S YC H I AT RY

E D I T O R I A L E D I T O R I
WHAT TO DO IF YOU SUSPECT WHAT TO DO IF YOU SUSPECT A PRION DISEASE A PRION DISEASE
A number of countries have established A number of countries have established surveillance centres to monitor the occursurveillance centres to monitor the occurrence of prion diseases. In the UK, rence of prion diseases. In the UK, psychiatrists who suspect that a patient psychiatrists who suspect that a patient has CJD should make a referral to the local has CJD should make a referral to the local neurological service which should contact neurological service which should contact the National CJD Surveillance Unit the National CJD Surveillance Unit in Edinburgh. Their website (http:// in Edinburgh. Their website (http:// www.cjd.ed.ac.uk) www.cjd.ed.ac.uk) includes information includes information about managing about managing CJD and addresses of CJD and addresses of support organisations. In the USA, doctors support organisations. In the USA, doctors should contact the National Prion Disease should contact the National Prion Disease Pathology Surveillance Center (http:// Pathology Surveillance Center (http:// www.cjdsurveillance.com). www.cjdsurveillance.com).
It has been difficult to find treatments. It has been difficult to find treatments. In 2004, the Medical Research Council in In 2004, the Medical Research Council in the UK launched the PRION-1 trial that the UK launched the PRION-1 trial that focuses initially on quinacrine, an antifocuses initially on quinacrine, an antimalarial that clears scrapie prion protein malarial that clears scrapie prion protein in cell culture. Pentosan polysulphate has in cell culture. Pentosan polysulphate has shown promising results in animals. It has shown promising results in animals. It has to be delivered directly to the brain. In a to be delivered directly to the brain. In a high-profile case, a father won a court bathigh-profile case, a father won a court battle to have pentosan polysulphate made tle to have pentosan polysulphate made available for his son. Attempts to find a available for his son. Attempts to find a vaccine for the abnormal prion protein are vaccine for the abnormal prion protein are still at an early stage. A better understandstill at an early stage. A better understanding of the mechanism of disease is offering ing of the mechanism of disease is offering novel treatment approaches, such as finding novel treatment approaches, such as finding agents that directly target prion protein. 
CONCLUSIONS CONCLUSIONS
Most of what we wrote in
Most of what we wrote in Advances in PsyAdvances in Psychiatric Treatment chiatric Treatment is still relevant 5 years is still relevant 5 years on, but prion diseases are better underon, but prion diseases are better understood. Almost two-thirds of people with stood. Almost two-thirds of people with vCJD will see a psychiatrist at some stage vCJD will see a psychiatrist at some stage of their illness (Spencer of their illness (Spencer et al et al, 2002 (Spencer et al et al, ). , 2002 . Psychiatrists need to know about prion Psychiatrists need to know about prion diseases; they need to complete good diseases; they need to complete good clinical assessments, particularly in unusual clinical assessments, particularly in unusual cases; and they need to be responsive to this cases; and they need to be responsive to this group of patients and their families. group of patients and their families. FortuFortunately, the worst predictions have not nately, the worst predictions have not materialised, but it is too early to lower materialised, but it is too early to lower our awareness of this group of disorders. our awareness of this group of disorders. 
